BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 25164809)

  • 21. Direct regulation of FNIP1 and FNIP2 by MEF2 sustains MTORC1 activation and tumor progression in pancreatic cancer.
    Xia L; Nie T; Lu F; Huang L; Shi X; Ren D; Lu J; Li X; Xu T; Cui B; Wang Q; Gao G; Yang Q
    Autophagy; 2024 Mar; 20(3):505-524. PubMed ID: 37772772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p62/SQSTM1 Cooperates with Hyperactive mTORC1 to Regulate Glutathione Production, Maintain Mitochondrial Integrity, and Promote Tumorigenesis.
    Lam HC; Baglini CV; Lope AL; Parkhitko AA; Liu HJ; Alesi N; Malinowska IA; Ebrahimi-Fakhari D; Saffari A; Yu JJ; Pereira A; Khabibullin D; Ogorek B; Nijmeh J; Kavanagh T; Handen A; Chan SY; Asara JM; Oldham WM; Diaz-Meco MT; Moscat J; Sahin M; Priolo C; Henske EP
    Cancer Res; 2017 Jun; 77(12):3255-3267. PubMed ID: 28512249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. mTORC1 signaling and the metabolic control of cell growth.
    Ben-Sahra I; Manning BD
    Curr Opin Cell Biol; 2017 Apr; 45():72-82. PubMed ID: 28411448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CREB is a novel nuclear target of PTEN phosphatase.
    Gu T; Zhang Z; Wang J; Guo J; Shen WH; Yin Y
    Cancer Res; 2011 Apr; 71(8):2821-5. PubMed ID: 21385900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Curcumin decreases Warburg effect in cancer cells by down-regulating pyruvate kinase M2 via mTOR-HIF1α inhibition.
    Siddiqui FA; Prakasam G; Chattopadhyay S; Rehman AU; Padder RA; Ansari MA; Irshad R; Mangalhara K; Bamezai RNK; Husain M; Ali SM; Iqbal MA
    Sci Rep; 2018 May; 8(1):8323. PubMed ID: 29844464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer.
    Zabala-Letona A; Arruabarrena-Aristorena A; Martín-Martín N; Fernandez-Ruiz S; Sutherland JD; Clasquin M; Tomas-Cortazar J; Jimenez J; Torres I; Quang P; Ximenez-Embun P; Bago R; Ugalde-Olano A; Loizaga-Iriarte A; Lacasa-Viscasillas I; Unda M; Torrano V; Cabrera D; van Liempd SM; Cendon Y; Castro E; Murray S; Revandkar A; Alimonti A; Zhang Y; Barnett A; Lein G; Pirman D; Cortazar AR; Arreal L; Prudkin L; Astobiza I; Valcarcel-Jimenez L; Zuñiga-García P; Fernandez-Dominguez I; Piva M; Caro-Maldonado A; Sánchez-Mosquera P; Castillo-Martín M; Serra V; Beraza N; Gentilella A; Thomas G; Azkargorta M; Elortza F; Farràs R; Olmos D; Efeyan A; Anguita J; Muñoz J; Falcón-Pérez JM; Barrio R; Macarulla T; Mato JM; Martinez-Chantar ML; Cordon-Cardo C; Aransay AM; Marks K; Baselga J; Tabernero J; Nuciforo P; Manning BD; Marjon K; Carracedo A
    Nature; 2017 Jul; 547(7661):109-113. PubMed ID: 28658205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural and inducible TH17 cells are regulated differently by Akt and mTOR pathways.
    Kim JS; Sklarz T; Banks LB; Gohil M; Waickman AT; Skuli N; Krock BL; Luo CT; Hu W; Pollizzi KN; Li MO; Rathmell JC; Birnbaum MJ; Powell JD; Jordan MS; Koretzky GA
    Nat Immunol; 2013 Jun; 14(6):611-8. PubMed ID: 23644504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Location-specific inhibition of Akt reveals regulation of mTORC1 activity in the nucleus.
    Zhou X; Zhong Y; Molinar-Inglis O; Kunkel MT; Chen M; Sun T; Zhang J; Shyy JY; Trejo J; Newton AC; Zhang J
    Nat Commun; 2020 Nov; 11(1):6088. PubMed ID: 33257668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase.
    Nobukuni T; Joaquin M; Roccio M; Dann SG; Kim SY; Gulati P; Byfield MP; Backer JM; Natt F; Bos JL; Zwartkruis FJ; Thomas G
    Proc Natl Acad Sci U S A; 2005 Oct; 102(40):14238-43. PubMed ID: 16176982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The rapid proximity labeling system PhastID identifies ATP6AP1 as an unconventional GEF for Rheb.
    Feng R; Liu F; Li R; Zhou Z; Lin Z; Lin S; Deng S; Li Y; Nong B; Xia Y; Li Z; Zhong X; Yang S; Wan G; Ma W; Wu S; Songyang Z
    Cell Res; 2024 May; 34(5):355-369. PubMed ID: 38448650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crosstalk between Edc4 and mammalian target of rapamycin complex 1 (mTORC1) signaling in mRNA decapping.
    Rahman H; Qasim M; Oellerich M; Asif AR
    Int J Mol Sci; 2014 Dec; 15(12):23179-95. PubMed ID: 25514416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are therapeutic effects of antiacne agents mediated by activation of FoxO1 and inhibition of mTORC1?
    Melnik BC; Schmitz G
    Exp Dermatol; 2013 Jul; 22(7):502-4. PubMed ID: 23800068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downregulated AKT-mTOR signaling pathway proteins in dorsolateral prefrontal cortex in Schizophrenia.
    Chadha R; Meador-Woodruff JH
    Neuropsychopharmacology; 2020 May; 45(6):1059-1067. PubMed ID: 31952070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual function of the PI3K-Akt-mTORC1 axis in myelination of the peripheral nervous system.
    Figlia G; Norrmén C; Pereira JA; Gerber D; Suter U
    Elife; 2017 Sep; 6():. PubMed ID: 28880149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An mTORC1-Dependent Mouse Model for Cardiac Sarcoidosis.
    Bueno-Beti C; Lim CX; Protonotarios A; Szabo PL; Westaby J; Mazic M; Sheppard MN; Behr E; Hamza O; Kiss A; Podesser BK; Hengstschläger M; Weichhart T; Asimaki A
    J Am Heart Assoc; 2023 Oct; 12(19):e030478. PubMed ID: 37750561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pim2 is required for maintaining multiple myeloma cell growth through modulating TSC2 phosphorylation.
    Lu J; Zavorotinskaya T; Dai Y; Niu XH; Castillo J; Sim J; Yu J; Wang Y; Langowski JL; Holash J; Shannon K; Garcia PD
    Blood; 2013 Aug; 122(9):1610-20. PubMed ID: 23818547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. De novo missense variants in RRAGC lead to a fatal mTORopathy of early childhood.
    Reijnders MRF; Seibt A; Brugger M; Lamers IJC; Ott T; Klaas O; Horváth J; Rose AMS; Craghill IM; Brunet T; Graf E; Mayerhanser K; Hellebrekers D; Pauck D; Neuen-Jacob E; Rodenburg RJT; Wieczorek D; Klee D; Mayatepek E; Driessen G; Bindermann R; Averdunk L; Lohmeier K; Sinnema M; Stegmann APA; Roepman R; Poulter JA; Distelmaier F
    Genet Med; 2023 Jul; 25(7):100838. PubMed ID: 37057673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapamycin reduces fibroblast proliferation without causing quiescence and induces STAT5A/B-mediated cytokine production.
    Gillespie ZE; MacKay K; Sander M; Trost B; Dawicki W; Wickramarathna A; Gordon J; Eramian M; Kill IR; Bridger JM; Kusalik A; Mitchell JA; Eskiw CH
    Nucleus; 2015; 6(6):490-506. PubMed ID: 26652669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NMDA receptor activation regulates sociability by its effect on mTOR signaling activity.
    Burket JA; Benson AD; Tang AH; Deutsch SI
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jul; 60():60-5. PubMed ID: 25703582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute effects of a ketone monoester, whey protein, or their coingestion on mTOR trafficking and protein-protein colocalization in human skeletal muscle.
    Hannaian SJ; Lov J; Cheng-Boivin Z; Abou Sawan S; Hodson N; Gentil BJ; Morais JA; Churchward-Venne TA
    Am J Physiol Cell Physiol; 2024 Jun; 326(6):C1769-C1775. PubMed ID: 38682238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.